Fulgent Genetics, Inc.
FLGT
$14.63
$0.382.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.42M | -6.61M | -18.96M | -11.53M | -5.89M |
| Total Depreciation and Amortization | 6.11M | 6.04M | 6.05M | 5.92M | 6.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.87M | 9.29M | 21.25M | 10.97M | 8.53M |
| Change in Net Operating Assets | -71.71M | 2.38M | -38.52M | -9.79M | 16.19M |
| Cash from Operations | -78.14M | 11.11M | -30.17M | -4.43M | 25.02M |
| Capital Expenditure | -4.98M | -6.05M | -6.83M | -4.72M | -3.78M |
| Sale of Property, Plant, and Equipment | 0.00 | 3.00K | 0.00 | 2.00K | 0.00 |
| Cash Acquisitions | 0.00 | 3.78M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.13M | 21.36M | 60.23M | 32.45M | -23.68M |
| Cash from Investing | 11.15M | 19.08M | 53.40M | 27.73M | -27.46M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -88.00K | -88.00K | -88.00K | -606.00K | -136.00K |
| Issuance of Common Stock | 1.00K | -- | -- | -- | 51.00K |
| Repurchase of Common Stock | -447.00K | -357.00K | -2.55M | -10.57M | -242.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -534.00K | -445.00K | -2.64M | -11.17M | -327.00K |
| Foreign Exchange rate Adjustments | 75.00K | 15.00K | 4.00K | 11.00K | -134.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.45M | 29.76M | 20.60M | 12.14M | -2.90M |